Qing Yi, MD, PhD

Projects

Projects per year 2016 2019 2021 2023 2028

• 2 Not started
• 3 Finished
• 7 Active

Projects per year

Search results

• Active

  Role of lipid metabolism in CD8+ T cell ferroptosis

  Yi, Q.

  9/19/23 → 8/31/28

  Project: Federal Funding Agencies

• DEVELOPING NOVEL CAR-T CELL THERAPY FOR HEMATOLOGIC MALIGNANCIES

  Yi, Q.

  7/1/23 → 6/30/26

  Project: Non Profit

• Targeting DKK1 with a DNA vaccine to prevent development of multiple myeloma

  Yi, Q.

  6/26/23 → 12/25/25

  Project: Federal Funding Agencies

• Role of ATRA in Overcoming Myeloma Resistance to Proteasome Inhibitors

  Yi, Q. & Wang, Q.

  8/31/21 → 2/29/24

  Project: State

• Potentiation of Multi-peptide Lung Cancer Vaccines with Immune Checkpoint Antagonist CA-170

  You, M. & Yi, Q.

  5/24/21 → 11/23/23

  Project: Federal Funding Agencies

• Role of tumor microenvironment-derived cholesterol in CD8+ T-cell exhaustion

  Yi, Q.

  8/1/19 → 7/31/24

  Project: Federal Funding Agencies

• CPRIT Recruitment of Established Investigator: Dr. Qing Yi

  Yi, Q.

  6/1/18 → 5/31/24

  Project: State

• Not started

  Adipose Tissue and Data Collection from Patients with and without the Diagnosis of Cancer at Houston Methodist Hospital

  Pingali, S. R., Chang, J. C., Esnaola, N. F., Sun, K. & Yi, Q.

  Project: Clinical Trial

• Sample and Data Collection for Hematologic disorders section, Houston Methodist Cancer Center

  Pingali, S. R., Ganguly, S., Heyne, K., Hu, C. A., Rice, L., Shah, S., Yang, J. & Yi, Q.

  Project: Clinical Trial

• Finished

  Targeting macrophages to sensitize myeloma to immune checkpoint blockade

  Yi, Q.

  3/1/19 → 2/28/23

  Project: Federal Funding Agencies

• Role of MIF in myeloma bone homing and drug response

  Yi, Q.

  1/1/19 → 12/31/22

  Project: Federal Funding Agencies

• A novel T-cell subset able to kill relapsed cancers

  Yi, Q.

  7/1/16 → 6/30/22

  Project: Federal Funding Agencies